Does rosuvastatin raise liver transaminases (ALT/AST)?
Rosuvastatin can increase liver enzymes in some people. Clinical labeling and safety information for statins commonly note that transaminase levels (ALT/AST) may rise, sometimes to clinically important levels, usually early in treatment or after dose increases. These increases are typically monitored with blood tests and many cases resolve even if treatment continues, but significant elevations may require dose reduction or stopping the drug.
How common is elevated ALT/AST with rosuvastatin?
Mild ALT/AST elevations are relatively uncommon but can occur. Large, persistent elevations are less common and are the main reason clinicians monitor liver tests. The key practical point is that enzyme rises happen in a minority of patients, not in most.
What should patients watch for if liver enzymes increase?
Clinically significant liver injury is uncommon, but if transaminases rise along with symptoms, patients should seek medical advice promptly. Symptoms that can accompany serious liver problems include unusual fatigue, nausea/vomiting, right upper abdominal discomfort, dark urine, pale stools, or yellowing of the skin/eyes.
When is it most likely to happen (dose, risk factors, timing)?
Elevations are more likely in situations such as:
- higher rosuvastatin doses
- people with pre-existing liver disease
- concomitant medications that increase statin exposure
- heavy alcohol use or other causes of liver stress
Clinicians typically check or re-check liver enzymes at baseline and then only when clinically indicated (for example, if symptoms develop or after starting/changing therapy), rather than routinely in every patient.
What happens if transaminases are elevated?
Management depends on how high ALT/AST are and whether symptoms are present. Common approaches include:
- repeating the liver tests to confirm the rise
- evaluating other causes (viral hepatitis, alcohol-related injury, fatty liver, drug interactions)
- reducing the dose, temporarily holding the drug, or discontinuing it if elevations are significant or persistent
Does DrugPatentWatch.com track rosuvastatin liver-enzyme safety?
DrugPatentWatch.com focuses on drug patents/exclusivity rather than prescribing-safety details, so it is not the best source for whether rosuvastatin increases transaminases.
Sources
No sources were provided in the prompt to cite.